And then we also, in a very small subset of low-grade gliomas, we find MYB and MYBL1 alterations, and that's mainly in angiocentric gliomas of other pediatric low-grade gliomas. And then of course ...

Survival time in patients with malignant glioma has modestly increased in recent years owing to advances in surgical and intraoperative imaging techniques, as well as the systematic implementation ...

The MYB alterations were especially frequent in one particularly rare pediatric glioma subtype, angiocentric glioma. In fact, all of the 19 angiocentric glioma samples had detectable MYB alterations, ...

Pixclara, a glioma-imaging agent, has been granted priority review by the FDA with a decision deadline of April 26, 2025. The agent targets LAT and LAT2 proteins, aiding in distinguishing glioma ...

In a specific type of PLGGs that occur in the brain's temporal lobe (angiocentric gliomas), in virtually all tumor samples from 19 patients there was a common gene rearrangement of two genes ...